These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 20388460)

  • 21. Clinical and psychosocial factors associated with fatigue in patients with Parkinson's disease.
    Havlikova E; Rosenberger J; Nagyova I; Middel B; Dubayova T; Gdovinova Z; W Groothoff J; P van Dijk J
    Parkinsonism Relat Disord; 2008; 14(3):187-92. PubMed ID: 17890136
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apathy and depression scales in Parkinson's disease: are they good enough?
    Schrag A
    J Neurol Sci; 2011 Nov; 310(1-2):216-9. PubMed ID: 21689829
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quality of life in relation to mood, coping strategies, and dyskinesia in Parkinson's disease.
    Montel S; Bonnet AM; Bungener C
    J Geriatr Psychiatry Neurol; 2009 Jun; 22(2):95-102. PubMed ID: 19150974
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictors of discrepancies in Parkinson's disease patient and caregiver ratings of apathy, disinhibition, and executive dysfunction before and after diagnosis.
    Schiehser DM; Liu L; Lessig SL; Song DD; Obtera KM; Burke Iii MM; Earl SR; Vincent Filoteo J
    J Int Neuropsychol Soc; 2013 Mar; 19(3):295-304. PubMed ID: 23351239
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Apathy and anhedonia rating scales in Parkinson's disease: critique and recommendations.
    Leentjens AF; Dujardin K; Marsh L; Martinez-Martin P; Richard IH; Starkstein SE; Weintraub D; Sampaio C; Poewe W; Rascol O; Stebbins GT; Goetz CG
    Mov Disord; 2008 Oct; 23(14):2004-14. PubMed ID: 18709683
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mood disturbances and cognitive functioning in Parkinson's disease: the effects of disease duration and side of onset of motor symptoms.
    Foster PS; Drago V; Mendez K; Witt JC; Crucian GP; Heilman KM
    J Clin Exp Neuropsychol; 2013; 35(1):71-82. PubMed ID: 23320400
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Executive function in Parkinson's disease and subcortical disorders.
    Elias JW; Treland JE
    Semin Clin Neuropsychiatry; 1999 Jan; 4(1):34-40. PubMed ID: 10229791
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Life goals of patients with Parkinson's disease: A pilot study on correlations with mood and cognitive functions.
    McNamara P; Durso R; Harris E
    Clin Rehabil; 2006 Sep; 20(9):818-26. PubMed ID: 17005505
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Testosterone deficiency and apathy in Parkinson's disease: a pilot study.
    Ready RE; Friedman J; Grace J; Fernandez H
    J Neurol Neurosurg Psychiatry; 2004 Sep; 75(9):1323-6. PubMed ID: 15314124
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Odor identification deficits identify Parkinson's disease patients with poor cognitive performance.
    Damholdt MF; Borghammer P; Larsen L; Ostergaard K
    Mov Disord; 2011 Sep; 26(11):2045-50. PubMed ID: 21638326
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Apathy and deep brain stimulation in Parkinson's disease].
    Lozachmeur C; Drapier D
    Rev Neurol (Paris); 2012; 168(8-9):620-3. PubMed ID: 22921249
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-motor dopamine withdrawal syndrome after surgery for Parkinson's disease: predictors and underlying mesolimbic denervation.
    Thobois S; Ardouin C; Lhommée E; Klinger H; Lagrange C; Xie J; Fraix V; Coelho Braga MC; Hassani R; Kistner A; Juphard A; Seigneuret E; Chabardes S; Mertens P; Polo G; Reilhac A; Costes N; LeBars D; Savasta M; Tremblay L; Quesada JL; Bosson JL; Benabid AL; Broussolle E; Pollak P; Krack P
    Brain; 2010 Apr; 133(Pt 4):1111-27. PubMed ID: 20237128
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlative factors of cognitive dysfunction in PD patients: a cross-sectional study from Southwest China.
    Zhang S; Ou R; Chen X; Yang J; Zhao B; Yuan X; Wei Q; Cao B; Shang HF
    Neurol Res; 2016 May; 38(5):434-40. PubMed ID: 27092858
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Unique and Combined Effects of Apathy and Depression on Cognition in Parkinson's Disease.
    Cohen ML; Aita S; Mari Z; Brandt J
    J Parkinsons Dis; 2015; 5(2):351-9. PubMed ID: 25769262
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Know thyself: Exploring interoceptive sensitivity in Parkinson's disease.
    Ricciardi L; Ferrazzano G; Demartini B; Morgante F; Erro R; Ganos C; Bhatia KP; Berardelli A; Edwards M
    J Neurol Sci; 2016 May; 364():110-5. PubMed ID: 27084227
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apathy in Parkinson's disease: more than just executive dysfunction.
    Martínez-Horta S; Pagonabarraga J; Fernández de Bobadilla R; García-Sanchez C; Kulisevsky J
    J Int Neuropsychol Soc; 2013 May; 19(5):571-82. PubMed ID: 23425620
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apathy, but not depression, reflects inefficient cognitive strategies in Parkinson's disease.
    Varanese S; Perfetti B; Ghilardi MF; Di Rocco A
    PLoS One; 2011 Mar; 6(3):e17846. PubMed ID: 21437255
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Occurrence risk and structure of depression in Parkinson disease with and without dementia: results from the GEPAD Study.
    Riedel O; Heuser I; Klotsche J; Dodel R; Wittchen HU;
    J Geriatr Psychiatry Neurol; 2010 Mar; 23(1):27-34. PubMed ID: 20042544
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Neuropsychiatric problems in patients with Parkinson's disease].
    Zhou MZ; Liu ZG; Gan J; Chen W; Lu LX; Wu JY
    Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(21):1442-5. PubMed ID: 18953846
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Management of psychiatric complications of Parkinson's disease].
    Fénelon G
    Rev Prat; 2005 Apr; 55(7):733-9. PubMed ID: 15966416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.